Page last updated: 2024-11-05

citronellal

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Citronellal is a monoterpenoid aldehyde with a fresh, citrusy odor that is commonly found in essential oils, particularly from citronella grass (Cymbopogon nardus). It is synthesized naturally through the mevalonic acid pathway, which involves a series of enzymatic reactions. Citronellal exhibits a range of biological activities, including antimicrobial, antifungal, insecticidal, and anti-inflammatory effects. It is widely used in the fragrance and flavor industries, as well as in insect repellents. The study of citronellal focuses on its potential applications in various fields, including medicine, agriculture, and cosmetics. Research efforts aim to explore its mechanisms of action, optimize its production, and develop novel formulations.'

citronellal: aldehyde of citronellol; found in citronella oil [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

citronellal : A monoterpenoid, the main component of citronella oil which gives it its distinctive lemon aroma. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
Citronellagenus[no description available]Cardiopteridaceae[no description available]
Cymbopogon winterianusspecies[no description available]PoaceaeA large family of narrow-leaved herbaceous grasses of the order Cyperales, subclass Commelinidae, class Liliopsida (monocotyledons). Food grains (EDIBLE GRAIN) come from members of this family. RHINITIS, ALLERGIC, SEASONAL can be induced by POLLEN of many of the grasses.[MeSH]

Cross-References

ID SourceID
PubMed CID7794
CHEMBL ID447944
CHEBI ID47856
SCHEMBL ID29275
MeSH IDM0281213

Synonyms (92)

Synonym
C1026
3,7-dimethyl-oct-6-enal
beta-citronellal
106-23-0
citronellal
NSC46106 ,
.beta.-citronellal
rhodinal
nsc-46106
citronellol,(d)
6-octenal,7-dimethyl-
3,7-dimethyl-6-octenal
citronellel
inchi=1/c10h18o/c1-9(2)5-4-6-10(3)7-8-11/h5,8,10h,4,6-7h2,1-3h
nsc 46106
einecs 203-376-6
fema no. 2307
2,3-dihydrocitral
hsdb 594
rhodinal (van)
ai3-00203
citronella
3,7-dimethyl-6-octen-1-al
d-rhodinal
citronella (natural)
6-octenal, 3,7-dimethyl-
3,7-dimethyloct-6-enal
(+/-)-citronellal, >=85%, fg
(+/-)-citronellal, natural, >=85%, fcc, fg
CHEBI:47856 ,
(+/-)-citronellal, >=95.0% (gc)
C17384
CHEMBL447944
AKOS000121405
A801397
NCGC00248328-01
8000-29-1
tox21_301195
dtxsid3041790 ,
NCGC00255093-01
dtxcid1021790
cas-106-23-0
unii-qb99vzz7gz
ec 203-376-6
ccris 8421
qb99vzz7gz ,
( inverted exclamation marka)-citronellal
FT-0623963
FT-0604386
FT-0623961
EPITOPE ID:112868
S5585
gtpl6300
3,7-dimethyloct-6-en-1-al
citronellal [mi]
citronellal [inci]
citronellal [fhfi]
(+/-)-citronellal
citronellal [fcc]
citronellal [hsdb]
SCHEMBL29275
racemic citronellal
(+/-) citronellal
J-502100
W-108770
(+/-)-3,7-dimethyl-6-octenal
mfcd00038090
FT-0699573
(+/-)-citronellal, analytical standard
beta -citronellal
fema 2307
AS-54400
Q61651085
HY-N7126
(rs)-citronellal
3,7-dimethyl-
CCG-266248
CS-W010931
P50009
EN300-21458
C3648
citronella oil, chinese 85/35
cymbopogon winterianus
essential oil obtained from the herbs of the plant
2,3-dihydrocitral 3,7-dimethyl-6-octenal 3,7-dimethyloct-6-enal 6-octenal
Z104497952
3,7-dimethyloct-6-enal 6-octenal
citric
natural isolate
citronellal extra rhodinal
3,7-dimethyl- citronellal
2,3-dihydrocitral 3,7-dimethyl-6-octenal

Research Excerpts

Overview

Citronellal (CT) is an acyclic monoterpene aldehyde isolated from lemon citronella. CT could ameliorate vascular endothelial dysfunction in atherosclerosis in our previous study. Whether CT can alleviate vascular endothelium dysfunction related with type 2 diabetes (T2DM) is still unknown.

ExcerptReferenceRelevance
"Citronellal (CT) is an acyclic monoterpene aldehyde isolated from lemon citronella, which could ameliorate vascular endothelial dysfunction in atherosclerosis in our previous study, however, whether CT can alleviate vascular endothelial dysfunction related with type 2 diabetes (T2DM) is still unknown. "( Citronellal alleviate macro- and micro-vascular damage in high fat diet / streptozotocin - Induced diabetic rats via a S1P/S1P1 dependent signaling pathway.
Chao, CY; Guo, YQ; Jiang, L; Li, P; Niu, QQ; Qiu, Y; Song, YT; Yin, YL; Zhang, J; Zhu, ML, 2022
)
3.61
"Citronellal (CT) is a monoterpene predominantly formed by the secondary metabolism of plants, producing antithrombotic, antiplatelet, and antihypertensive activities."( Citronellal prevents endothelial dysfunction and atherosclerosis in rats.
Guo, C; Jing, Y; Li, P; Li, QZ; Liu, Z; Lu, JX; Niu, HF; Ou, WS; Song, P; Xu, J; Yin, YL; Zhu, ML, 2019
)
2.68
"Citronellal is a monoterpene present in the oil of many species, including Cymbopogon winterianus Jowitt (Poaceae)."( Citronellal, a monoterpene present in Java citronella oil, attenuates mechanical nociception response in mice.
Almeida, JR; Camargo, EA; de Oliveira, AP; de Oliveira, MG; de Santana, MT; De Sousa, DP; Quintans-Júnior, LJ; Santana, DG; Santana, MF, 2013
)
3.28
"Citronellal is a major component of Corymbia citriodora and Cymbopogon nardus essential oils. "( Enantioselective effects of (+)- and (-)-citronellal on animal and plant microtubules.
Abu-Abied, M; Altshuler, O; Chaimovitsh, D; Dudai, N; Frucht, H; Sadot, E; Shechter, A, 2013
)
2.1
"Citronellal (CT) is a monoterpene with antinociceptive acute effect. "( Docking, characterization and investigation of β-cyclodextrin complexed with citronellal, a monoterpene present in the essential oil of Cymbopogon species, as an anti-hyperalgesic agent in chronic muscle pain model.
Araújo, AA; Brito, RG; Coutinho, HD; Guimarães, AG; Menezes, IR; Menezes, PP; Oliveira, MA; Quintans, JS; Quintans-Júnior, LJ; Santos, MR; Santos, PL; Serafini, MR, 2016
)
2.11
"Citronellal is a monoterpene reported to be a major component of the essential oils in various aromatic species of plants. "( Antinociceptive effect of citronellal in mice.
Almeida, JR; Barreto, FJ; Bonjardim, LR; De Sousa, DP; Lima, JT; Melo, MS; Quintans-Júnior, LJ; Sena, LC, 2010
)
2.1
"Citronellal (CT) is a monoterpenoid and the major constituent of the mixture of terpenoids that give the citronella oil its lemon scent. "( Antinociceptive action and redox properties of citronellal, an essential oil present in lemongrass.
Araújo, AA; Bonjardim, LR; Caregnato, FF; da Rocha, RF; da Silva, FA; de Sousa, DP; dos Santos, JP; Gelain, DP; Melo, MS; Moreira, JC; Quintans-Júnior, L, 2011
)
2.07

Actions

ExcerptReferenceRelevance
"The citronellal was able to increase the pain threshold in the DA test (p < 0.001, p < 0.01, and p < 0.05) and in the PGE₂ test at all times (p < 0.001 and p < 0.05)."( Citronellal, a monoterpene present in Java citronella oil, attenuates mechanical nociception response in mice.
Almeida, JR; Camargo, EA; de Oliveira, AP; de Oliveira, MG; de Santana, MT; De Sousa, DP; Quintans-Júnior, LJ; Santana, DG; Santana, MF, 2013
)
2.31

Toxicity

ExcerptReferenceRelevance
" In the acute toxicity test, the LD10 and LD50 of free EcEO was 1999 and 2653 mg/kg, respectively, while the LD10 and LD50 of nanoencapsulated EcEO was 1121 and 1681 mg/kg, respectively."( Efficacy of free and nanoencapsulated Eucalyptus citriodora essential oils on sheep gastrointestinal nematodes and toxicity for mice.
Araújo Filho, JV; Bevilaqua, CM; Camurça-Vasconcelos, AL; Macedo, IT; Magalhães, RD; Paula, HC; Ribeiro, JC; Ribeiro, WL; Santos, JM, 2014
)
0.4

Bioavailability

ExcerptReferenceRelevance
" The bioavailability of digoxin after oral administration decreased significantly to 75."( Effects of citronellal, a monoterpenoid in Zanthoxyli Fructus, on the intestinal absorption of digoxin in vitro and in vivo.
Adachi, I; Kawakami, J; Kitazawa, H; Takagi, A; Yoshida, N, 2006
)
0.72
" However, additional bioavailability and toxicity studies must be carried out before these products can be used for the chemical control of oral biofilms."( The antifungal and antibiofilm activity of Cymbopogon nardus essential oil and citronellal on clinical strains of Candida albicans.
Cordeiro, LV; de Albuquerque Tavares Carvalho, A; de Figuerêdo Silva, D; de Oliveira Lima, E; de Pontes, MLC; Figueiredo, PTR; Trindade, LA, 2022
)
0.95

Dosage Studied

ZY4R/citronellal combination enhanced antimicrobial efficacies without compromising cell selectivity, contributing to decreasing drug dosage and improving biosafety.

ExcerptRelevanceReference
" Meanwhile, ZY4R/citronellal combination enhanced antimicrobial efficacies without compromising cell selectivity, contributing to decreasing drug dosage and improving biosafety."( Antimicrobial peptides in combination with citronellal efficiently kills multidrug resistance bacteria.
He, S; Li, X; Shan, A; Wang, J; Wei, Y; Yang, Z, 2023
)
1.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
antifungal agentAn antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
monoterpenoidAny terpenoid derived from a monoterpene. The term includes compounds in which the C10 skeleton of the parent monoterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).
aldehydeA compound RC(=O)H, in which a carbonyl group is bonded to one hydrogen atom and to one R group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
citronellol degradation112

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency30.63790.001022.650876.6163AID1224838
progesterone receptorHomo sapiens (human)Potency0.17230.000417.946075.1148AID1346795
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (130)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (3.08)18.7374
1990's7 (5.38)18.2507
2000's25 (19.23)29.6817
2010's65 (50.00)24.3611
2020's29 (22.31)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 62.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index62.63 (24.57)
Research Supply Index4.93 (2.92)
Research Growth Index5.26 (4.65)
Search Engine Demand Index102.64 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (62.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (1.47%)5.53%
Reviews3 (2.21%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other131 (96.32%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]